ExploreWatchlistsPricing
  1. JP-listed companies
  2. SUZUKEN CO.,LTD.
  3. Financials
  4. Total cash & short-term investments

SUZUKEN CO.,LTD. (9987)

Market cap
¥428.4B
P/E ratio
13x
Suzuken distributes prescription drugs, medical devices and diagnostic products to healthcare providers across Japan through a nationwide network of subsidiaries.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndTotal cash & short-term investments (Million JPY)YoY (%)
Mar 31, 2025141,582-41.52%
Mar 31, 2024242,112+25.64%
Mar 31, 2023192,703-4.35%
Mar 31, 2022201,463-5.02%
Mar 31, 2021212,120+0.23%
Mar 31, 2020211,629-20.10%
Mar 31, 2019264,883+11.92%
Mar 31, 2018236,674+68.53%
Mar 31, 2017140,438+3.80%
Mar 31, 2016135,295+3.68%
Mar 31, 2015130,495

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat